Clinical trials: While Receiving Tedizolid Therapy Between July 2019 and December 2024
Adult Patients Developing Optic or Peripheral Neuropathy, While Receiving Tedizolid Therapy Between July 2019 and December 2024
Tedizolid Neuropathies
Tedizolid is a new oxazolidinone, related to linezolid. It has obtained marketing authorization for the treatment of skin and soft tissue infections.
- Trial name
- NCT07143240
- Testing
- Determine patient demographic and clinical characteristics at baseline
- Where
- France
- Volunteers
- 5 people
- Sponsor
- Hospices Civils de Lyon